Magnera Corp

Magnera Corp(MAGN)の株式分析

$12.560

+0.162 (+1.29%)終値時点

Loading chart…
High
12.710
Open
12.290
VWAP
12.45
Vol
450.56K
Mkt Cap
Low
12.090
Amount
5.61M
EV/EBITDA, TTM
5.78

Magnera Corporation is engaged in the specialty materials and nonwovens industry. The Company’s operations are organized into two operating segments: Americas and Rest of the World. The Americas segment consists of sites in North America and South America that manufacture a range of products and components of personal care and consumer solution products and components of products including medical garments, wipes, dryer sheets, face masks, filtration, baby diapers and adult incontinence. The Rest of World segment consists of sites throughout Europe and China that manufacture a broad collection of personal care and consumer solution products and components of products including medical garments, wipes, face masks, cable wrap, filtration, baby diapers and adult incontinence. Its solutions include nonwovens, and films and laminates. Its nonwovens include Spunmelt, Airlaid, Spunlace, Through Air Bonded, and Needlepunch. Its films and laminates include Typar, Chicopee, Sontara and Tubex.

magnera.com

AI analysis of Magnera Corp (MAGN)

hold

Magnera Corp is currently not a strong buy due to mixed signals. The current price is $12.4, which is close to the 52-week low of $7.815, indicating potential downside risk. The forward P/E ratio is 13.7, suggesting that while the stock may be undervalued, the earnings outlook remains uncertain with recent losses. Additionally, the RSI is at 48.3, indicating a neutral momentum, which does not suggest a strong buying opportunity at this time. The main risk is the recent earnings miss, with a reported EPS of -0.56, which could undermine investor confidence moving forward.

バリュエーション指標

The current forward P/E ratio for Magnera Corp (MAGN) is 13.70, compared to its 5-year average forward P/E of 33.31.

Forward P/E

Fair
5Y Average P/E
33.31
Current P/E
13.70
割高
68.98
割安
-2.36

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
8.32
Current EV/EBITDA
5.78
割高
11.98
割安
4.66

Forward P/S

Fair
5Y Average P/S
0.14
Current P/S
0.13
割高
0.17
割安
0.11

Alphio AI Price Scenarios for MAGN

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%MAGN

$14.41

シナリオ価格

B

Base

Base · 50%MAGN

$13.21

シナリオ価格

B

Bear

Bear · 25%MAGN

$12.75

シナリオ価格

Whales holding MAGN

L

Loews Corporation

+ HoldingMAGN

+15.89%

3M Return

イベントタイムライン

2026-06-15 (ET)

05:30:00

Magnera Sells Caerphilly Operations to Polyart Group

2025-11-19 (ET)

19:22:12

Magnera projects adjusted EBITDA of $380M-$410M for FY26

19:21:34

Magnera announces Q4 adjusted EBITDA of $90M, up from $66M a year ago.

2025-11-18 (ET)

09:32:07

Innventure Names Brown as Lead Independent Director

2025-09-29 (ET)

16:45:39

Magnera reveals plans to strategically withdraw from Argentina

ニュース

MAGN FAQ — answered by Alphio AI

Magnera Corporation is engaged in the specialty materials and nonwovens industry. The Company’s operations are organized into two operating segments: Americas and Rest of the World. The Americas segment consists of sites in North America and South America that manufacture a range of products and components of personal care and consumer solution products and components of products including medical garments, wipes, dryer sheets, face masks, filtration, baby diapers and adult incontinence. The Rest of World segment consists of sites throughout Europe and China that manufacture a broad collection of personal care and consumer solution products and components of products including medical garments, wipes, face masks, cable wrap, filtration, baby diapers and adult incontinence. Its solutions include nonwovens, and films and laminates. Its nonwovens include Spunmelt, Airlaid, Spunlace, Through Air Bonded, and Needlepunch. Its films and laminates include Typar, Chicopee, Sontara and Tubex. It operates in the Consumer Cyclicals sector.

Magnera Corp is currently not a strong buy due to mixed signals. The current price is $12.4, which is close to the 52-week low of $7.815, indicating potential downside risk. The forward P/E ratio is 13.7, suggesting that while the stock may be undervalued, the earnings outlook remains uncertain with recent losses. Additionally, the RSI is at 48.3, indicating a neutral momentum, which does not suggest a strong buying opportunity at this time. The main risk is the recent earnings miss, with a reported EPS of -0.56, which could undermine investor confidence moving forward.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める